Key facts
- Notable investors include Gimv.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Inter-regional Institute of Cancerology
- ·The full record, as it builds
Funding rounds
No funding rounds for Inter-regional Institute of Cancerology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inter-regional Institute of Cancerology
Provider of advanced cancer treatment services including radiotherapy, chemotherapy, and nuclear medicine intended to offer personalized and cutting-edge care to cancer patients across multiple specialized centers. The company offers comprehensive oncology treatments, thereby utilizing state-of-the-art technologies and a team of medical experts to deliver high-quality care to cancer patients across its specialized centers.
- Sector
- Healthcare
- HQ
- Le Mans, France
- Founded
- 2016
- Employees
- 220
- Website
- i-l-c.fr/
- Ownership
- Privately Held (backing)
Inter-regional Institute of Cancerology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inter-regional Institute of Cancerology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inter-regional Institute of Cancerology in its N-PORT filings yet. We sweep new filings monthly.